Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
British Journal of Cancer
|
August 9, 2017
GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
J Mora, A Castañeda, S Perez-Jaume, et al.
Biology of Reproduction
|
June 27, 2020
CRISPR/Cas9-based genome editing in mice uncovers 13 testis- or epididymis-enriched genes individually dispensable for male reproduction†
Jiang Sun, Yonggang Lu, Kaori Nozawa, et al.
Molecular Cancer Research : MCR
|
March 20, 2021
EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma
Jennifer A Jiménez, April A Apfelbaum, Allegra G Hawkins, et al.
Transplantation Proceedings
|
November 1, 2015
Does the Pulsatile Preservation Machine Have Any Impact in the Discard Rate of Kidneys From Older Donors After Brain Death?
D Paredes-Zapata, A Ruiz-Arranz, C Rodriguez-Villar, et al.
ESMO Open
|
August 30, 2024
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study
A Rodriguez-Vida, B P Valderrama, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)
J Martin-Broto, A Redondo, C Valverde, et al.
European Urology
|
December 13, 2002
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG)
J R Germà-Lluch, X Garcia del Muro, P Maroto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 2010
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study
J Martin-Broto, A Gutierrez, X Garcia-Del-Muro, et al.
Biology of Reproduction
|
June 16, 2019
CRISPR/Cas9-mediated genome editing reveals 30 testis-enriched genes dispensable for male fertility in mice†
Yonggang Lu, Seiya Oura, Takafumi Matsumura, et al.
ESMO Open
|
April 11, 2022
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy
E Grande, T Alonso-Gordoa, O Reig, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
British Journal of Cancer
|
August 9, 2017
GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
J Mora, A Castañeda, S Perez-Jaume, et al.
Biology of Reproduction
|
June 27, 2020
CRISPR/Cas9-based genome editing in mice uncovers 13 testis- or epididymis-enriched genes individually dispensable for male reproduction†
Jiang Sun, Yonggang Lu, Kaori Nozawa, et al.
Molecular Cancer Research : MCR
|
March 20, 2021
EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma
Jennifer A Jiménez, April A Apfelbaum, Allegra G Hawkins, et al.
Transplantation Proceedings
|
November 1, 2015
Does the Pulsatile Preservation Machine Have Any Impact in the Discard Rate of Kidneys From Older Donors After Brain Death?
D Paredes-Zapata, A Ruiz-Arranz, C Rodriguez-Villar, et al.
ESMO Open
|
August 30, 2024
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study
A Rodriguez-Vida, B P Valderrama, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)
J Martin-Broto, A Redondo, C Valverde, et al.
European Urology
|
December 13, 2002
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG)
J R Germà-Lluch, X Garcia del Muro, P Maroto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 2010
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study
J Martin-Broto, A Gutierrez, X Garcia-Del-Muro, et al.
Biology of Reproduction
|
June 16, 2019
CRISPR/Cas9-mediated genome editing reveals 30 testis-enriched genes dispensable for male fertility in mice†
Yonggang Lu, Seiya Oura, Takafumi Matsumura, et al.
ESMO Open
|
April 11, 2022
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy
E Grande, T Alonso-Gordoa, O Reig, et al.
Page
of 11